Frisch Medical Devices
Frisch Medical Devices is an Indian privately-held manufacturer founded in 2014 that designs and produces interventional cardiology devices — drug-eluting stents, PTCA balloons, drug-coated balloons, and cardiac accessories — selling directly to hospitals and cathlabs across India and eight export markets.
- Company typePrivate
- Founded2014
- HeadquartersAhmedabad, India
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Frisch Medical Devices does
Frisch Medical Devices Pvt. Ltd. is an Indian privately-held manufacturer of interventional cardiology medical devices founded in 2014 and headquartered in Ahmedabad, Gujarat, with manufacturing in Palghar, Maharashtra. The company serves hospitals and cardiac catheterization laboratories (cathlabs), selling through a direct B2B field-sales motion to interventional cardiologists performing PCI/PTCA procedures. Its go-to-market spans India plus eight export markets (Russia, Serbia, Indonesia, Peru, Mexico, Thailand, Chile, Malaysia), supported by CE, ISO 13485:2016 (DNV Norway), GMP, CDSCO, and country-specific health-ministry approvals.
The product portfolio spans the full coronary intervention workflow: drug-eluting coronary stents (MedSure with Sirolimus and EvroSure with Everolimus on a 59µm cobalt-chromium hybrid-cell platform with biodegradable PLLA/PLGA polymer), PTCA dilatation balloons (Glider SC/NC/CTO variants), a Sirolimus Drug-Coated Balloon (Mamba), an aspiration catheter (ThromboCatch), and a broad accessories line (FLUTE inflation devices, Assure control syringes, Connect hemostasis Y-connectors, Unite manifolds, Steer introducer sheaths, Protect TRCD band, Resist pressure monitoring lines). Manufacturing is conducted in a Class 10,000 cleanroom with ETO sterilization, and the company self-describes as the first and only fully backward-integrated Cardiac Accessories manufacturer in India, producing its own components from proprietary moulds. It also offers OEM/Own Brand Labelling services to third parties.
Revenue is generated almost entirely through hardware sales of branded cardiac devices to healthcare institutions; pricing is not publicly disclosed and follows a quote-based B2B model typical of medical devices. The company is founder-led, privately held with no disclosed institutional investors or funding rounds, and does not publicly report revenue. Geographic mix is heavily weighted toward India and emerging markets, with Europe accessed via CE marking rather than US FDA approval, which constrains the addressable market for premium-tier customers but positions the portfolio for cost-sensitive segments.
Frisch Medical Devices firmographics
Firmographics- Name
- Frisch Medical Devices
- Legal name
- Frisch Medical Devices Pvt. Ltd.
- Website
- https://frischmedical.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Short description
- Frisch Medical Devices is an Indian privately-held manufacturer founded in 2014 that designs and produces interventional cardiology devices — drug-eluting stents, PTCA balloons, drug-coated balloons, and cardiac accessories — selling directly to hospitals and cathlabs across India and eight export markets.
- Ownership category
- akta.pro rank
Frisch Medical Devices industry classification
Industry- Product category
- Interventional Cardiology Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)
Keywords
Where Frisch Medical Devices is headquartered
LocationHeadquarters
- HQ city
- Ahmedabad
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Frisch Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Cardiac Medical Device Sales: Sale of cardiac stents (Sirolimus and Everolimus drug-eluting), PTCA balloons (SC/NC/CTO), drug-coated balloons, and cardiac accessories to hospitals and cathlabs. Revenue is generated through direct sales to healthcare institutions across multiple regulated markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Frisch Medical Devices product offering
Product offeringCore offering
Frisch Medical Devices designs, develops, and manufactures interventional cardiology consumables for the treatment of coronary artery disease, including drug-eluting coronary stents (MedSure Sirolimus and EvroSure Everolimus), PTCA balloon catheters (Glider SC/NC/CTO), a Paclitaxel drug-coated balloon (Mamba), and an aspiration catheter (ThromboCatch). The company complements this core portfolio with a comprehensive cardiac accessories family — PTCA inflation devices (FLUTE), control syringes (Assure), Y connectors (Connect), manifolds (Unite), introducer sheaths (Steer-R and Steer-F), TR bands (Protect), pressure monitoring and extension lines (Resist), puncture needles, and angioclosure pads — and offers OEM/OBL contract manufacturing services from a Class 10,000 cleanroom facility in Palghar, Maharashtra.
Product overview
Frisch Medical Devices is a fully backward-integrated cardiac medical devices company that designs, develops, and manufactures interventional cardiology products. The portfolio centers on Drug-Eluting Coronary Stents (MedSure with Sirolimus and EvroSure with Everolimus), PTCA Balloon Catheters (Glider SC/NC/CTO and Mamba Drug Coated Balloon), and a comprehensive range of Cardiac Accessories including ThromboCatch Aspiration Catheter, PTCA Inflation Devices (FLUTE-R/I/C/G), Control Syringes (Assure), Hemostasis Y Connectors (Connect-PP/ST/DS/PC), Manifolds (Unite), Introducer Sheaths (Steer-R and Steer-F kits), TRCD Band (Protect), Pressure Monitoring Lines (Resist), and other accessories. The company also offers OEM/OBL manufacturing services. All products are manufactured in-house using proprietary molds for component production.
Differentiator
Problem solved
Functional benefit
Brands
- EvroSure: Cobalt Chromium Everolimus Eluting Coronary Stent System
- MedSure
- Mamba
- ThromboCatch
- Glider
- FLUTE
- Assure
- Connect-PP
- Connect-PC
- Connect-ST
- Connect-DS
- Unite
- Steer-R
- Steer-F
- Protect
- Resist
Products and services
- MedSure (Sirolimus Drug-Eluting Coronary Stent) Sirolimus-eluting coronary stent system built on a cobalt-chromium L605 platform with a proprietary polymer coating for restenosis prevention in percutaneous coronary intervention. Targeted at interventional cardiologists and cathlab teams treating coronary artery disease.
- EvroSure (Everolimus Drug-Eluting Coronary Stent) Everolimus-eluting coronary stent system on a cobalt-chromium L605 platform with PLLA/PLGA biodegradable polymer coating designed to reduce long-term polymer exposure while supporting vessel healing. Intended for interventional cardiologists performing PCI procedures.
- Glider PTCA Balloon Catheters (Semi-Compliant, Non-Compliant, CTO) Family of PTCA balloon catheters (semi-compliant Glider SC, non-compliant Glider NC, and CTO Glider CTO) constructed on a polyamide (Nylon) balloon platform with low-friction, low-crossing-profile design and hydrophilic coating for lesion preparation and dilation. Intended for use by interventional cardiologists in PCI procedures.
- Mamba Drug-Coated Balloon (Paclitaxel) Paclitaxel drug-coated balloon catheter that uses proprietary nano-sphere coating technology to deliver uniform drug transfer to the vessel wall while minimizing particulate release. Designed for interventional cardiology use in lesions where a drug-coated balloon strategy is clinically indicated.
- ThromboCatch Aspiration Catheter Large-bore aspiration catheter indicated for manual thrombectomy in acute myocardial infarction cases. Targeted at interventional cardiologists performing primary PCI for thrombus-laden lesions.
- FLUTE-R PTCA Inflation Device (25 ATM Rated) PTCA inflation device rated for 25 ATM with ergonomic high-pressure handle and a clear barrel gauge for precise pressure visualization. Used by cathlab teams during PCI to inflate and deflate angioplasty balloons.
- FLUTE-I PTCA Inflation Device (30 ATM) PTCA inflation device rated up to 30 ATM with an ergonomic handle design and clear barrel gauge for accurate pressure delivery during PCI. Used by interventional cardiologists and cathlab nurses.
- FLUTE-C PTCA Inflation Device (Compact) Compact PTCA inflation device with ergonomic grip design for cathlab use, providing pressure delivery and visualization during PCI in a smaller form factor than standard devices.
- FLUTE-G PTCA Inflation Device (Giant) Large-barrel PTCA inflation device with an ergonomic grip designed for high-volume cathlab PCI use, offering clear pressure visualization during balloon inflation.
- Assure Control Syringe Control syringe used in cathlab procedures to deliver precise volumes of contrast media and saline, supporting both diagnostic angiography and interventional workflows. Used by cathlab technicians and interventional cardiologists.
- Connect Push Pull Hemostasis Y Connector Hemostasis Y connector with a push-pull mechanism allowing easy insertion and manipulation of guide wires and interventional devices while maintaining haemostasis during PCI. Used by cathlab teams.
- Connect Push Click Hemostasis Y Connector Hemostasis Y connector with a push-click mechanism for click-secure fixation of interventional devices during PCI, providing haemostasis while enabling rapid device exchanges. Used by cathlab teams.
- Connect Screw Type Hemostasis Y Connector Hemostasis Y connector with a screw-type mechanism providing torque-controlled haemostasis around guide wires and interventional devices during PCI. Used by interventional cardiologists.
- Connect Double Screw Hemostasis Y Connector Hemostasis Y connector with a double-screw mechanism for independent screw-controlled haemostasis during complex PCI procedures. Used by interventional cardiology teams.
- Unite 2-Port and 3-Port Manifolds 2-port and 3-port manifold stopcocks used to manage contrast, saline, and waste lines during diagnostic and interventional cathlab procedures. Used by cathlab technicians and interventional cardiologists.
- Steer-R Kit (Radial Introducer Sheath) Introducer sheath kit designed for transradial arterial access in coronary diagnostic and interventional procedures, providing smooth entry and haemostasis. Used by interventional cardiologists performing transradial PCI.
- Steer-F Kit (Femoral Introducer Sheath) Introducer sheath kit designed for transfemoral arterial access in coronary diagnostic and interventional procedures. Used by interventional cardiologists performing transfemoral PCI.
- Protect TRCD Band (TransRadial Compression Device) Transradial compression device band applied at the radial puncture site to achieve haemostasis following transradial catheterization. Used in cathlab recovery areas by nursing staff and interventional cardiologists.
- Resist Pressure Monitoring Line Pressure monitoring line used to connect invasive arterial pressure transducers for real-time pressure waveform monitoring during diagnostic and interventional cathlab procedures. Used by cathlab technicians and interventional cardiologists.
- Extension Lines / Power Injection Lines Extension lines and power injection lines for cathlab connectivity, supporting contrast power injection and remote catheter manipulation during angiography. Used in cathlab procedural setups.
- Puncture Needles Arterial puncture needles used to obtain vascular access for diagnostic coronary angiography and interventional cardiology procedures. Used by interventional cardiologists and cathlab staff.
- Angioclosure Pad Angioclosure haemostasis pad placed at the femoral or radial puncture site to assist in achieving haemostasis after catheterization. Used in cathlab recovery areas.
- OEM / OBL Contract Manufacturing Services OEM / OBL contract manufacturing services for interventional cardiology devices, catheter sub-assemblies, and related accessories, produced in the company's Class 10,000 cleanroom facility using proprietary in-house moulds and in-house ETO sterilization. Targeted at global medical device brand owners seeking a backward-integrated Indian manufacturing partner.
Quantifiable outcome
- Polymer biodegradation in 6-7 weeks for Everolimus stents
- +3 more outcomes
Companies that use Frisch Medical Devices
Customer profileSegments2 records
Ideal customer profiles2 records
Frisch Medical Devices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Frisch Medical Devices partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
Frisch Medical Devices competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights6 records
Customer concentration
Frisch Medical Devices compliance and trust
Trust signalCompliance6 records
Frisch Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Frisch Medical Devices leadership team
Management profileNumber of profiles
Profiles1 record
Frisch Medical Devices funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Frisch Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Frisch Medical Devices
What does Frisch Medical Devices do?
Frisch Medical Devices designs, develops, and manufactures interventional cardiology consumables for the treatment of coronary artery disease, including drug-eluting coronary stents (MedSure Sirolimus and EvroSure Everolimus), PTCA balloon catheters (Glider SC/NC/CTO), a Paclitaxel drug-coated balloon (Mamba), and an aspiration catheter (ThromboCatch). The company complements this core portfolio with a comprehensive cardiac accessories family — PTCA inflation devices (FLUTE), control syringes (Assure), Y connectors (Connect), manifolds (Unite), introducer sheaths (Steer-R and Steer-F), TR bands (Protect), pressure monitoring and extension lines (Resist), puncture needles, and angioclosure pads — and offers OEM/OBL contract manufacturing services from a Class 10,000 cleanroom facility in Palghar, Maharashtra.
Is Frisch Medical Devices a public or private company?
Frisch Medical Devices is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Frisch Medical Devices founded?
Frisch Medical Devices was founded in 2014.
Where is Frisch Medical Devices based?
Frisch Medical Devices is headquartered in Ahmedabad, India, in the Asia region.
How does Frisch Medical Devices make money?
One revenue line is on record: cardiac Medical Device Sales.
Does Frisch Medical Devices have an API?
No public API is recorded for Frisch Medical Devices.
What industry is Frisch Medical Devices in?
Frisch Medical Devices's product category is Interventional Cardiology Devices. Its primary akta.pro industry code is HLAHAFAA, Coronary Stents & Drug-Eluting Technologies. Its NAICS code is 339112 and its SIC code is 3841.